BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10768231)

  • 1. [Molecular biology diagnosis of bladder carcinoma].
    Rübben H; Otto T
    Urologe A; 2000 Mar; 39(2):178-81. PubMed ID: 10768231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
    Denzinger S; Hartmann A; Hofstaedter F; Knuechel R; Wild PJ; Zaak D; Stief C; Wieland WF; Stoehr R; Burger M
    Urologe A; 2007 Sep; 46(9):1126-8. PubMed ID: 17634910
    [No Abstract]   [Full Text] [Related]  

  • 3. Bladder cancer: state-of-the-art care.
    Droller MJ
    CA Cancer J Clin; 1998; 48(5):269-84. PubMed ID: 9742894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern diagnosis of bladder cancer].
    Denzinger S; Wieland WF; Otto W
    MMW Fortschr Med; 2008 Jan; 150(5):36-9; quiz 41. PubMed ID: 18300553
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphangiogenesis axis in bladder carcinoma. An analysis with tissue microarray technology].
    Herrmann E; Eltze E; Bierer S; Hertle L; Wülfing C
    Urologe A; 2007 Sep; 46(9):1254-6. PubMed ID: 17676294
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum and urinary endocan levels for bladder cancer diagnosis.
    Hu ZD
    Ann Clin Biochem; 2016 Nov; 53(6):717. PubMed ID: 27141014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polymerase chain reaction in the urinary diagnosis of bladder cancer].
    Beecken WD; Jonas D
    Urologe A; 2003 Jul; 42(7):922-6. PubMed ID: 12898035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
    Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
    Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
    [No Abstract]   [Full Text] [Related]  

  • 9. A proposed score for assessing progression in pT1 high-grade urothelial carcinoma of the bladder.
    Raspollini MR; Minervini A; Lapini A; Lanzi F; Rotellini M; Baroni G; Carini M
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):218-27. PubMed ID: 22820663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and staging of bladder cancer.
    Cummings KB; Barone JG; Ward WS
    Urol Clin North Am; 1992 Aug; 19(3):455-65. PubMed ID: 1636230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Upgrading methods of early detection of recurrent tumors of the bladder].
    Aleksandrov VP; Startsev VIu; Koren'kov DG; Karelin MI
    Urologiia; 2002; (6):51-5. PubMed ID: 12577582
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
    Lin YL; Sun G; Liu XQ; Li WP; Ma JG
    J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.
    Rodríguez-Alonso A; Pita-Fernández S; González-Carreró J; Nogueira-March JL
    Eur Urol; 2002 Feb; 41(2):182-8; discussion 188-9. PubMed ID: 12074407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
    Sugano K; Kakizoe T
    Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of patients with bladder cancer: clinical versus pathologic staging.
    Cummings KB
    Prog Clin Biol Res; 1984; 162A():33-53. PubMed ID: 6483916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma].
    Grimm MO; Burchardt M; Schulz WA
    Urologe A; 2003 May; 42(5):650-9. PubMed ID: 12750800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of bladder cancer].
    Jokisch JF; Ganswindt U; Hentrich M; Stief C; Karl A
    MMW Fortschr Med; 2015 Nov; 157(20):42-5. PubMed ID: 26977514
    [No Abstract]   [Full Text] [Related]  

  • 19. What is new in bladder cancer imaging.
    Barentsz JO; Witjes JA; Ruijs JH
    Urol Clin North Am; 1997 Aug; 24(3):583-602. PubMed ID: 9275980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in pathology and molecular genetics of small cell carcinoma of the urinary bladder].
    Cheng L; Huang WB; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):700-3. PubMed ID: 18194608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.